Metagenomi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	32.77	27.39	140.6	184.44	39.3
Short-Term Investments	151.34	220.92	130.58	177.69	68.86
Cash & Short-Term Investments	184.11	248.31	271.18	362.13	108.15
Cash Growth	-32.95%	-8.43%	-25.11%	234.83%	-
Accounts Receivable	0.96	1.26	2.45	-	-
Other Receivables	-	-	-	1.27	-
Total Trade Receivables	0.96	1.26	2.45	1.27	-
Other Current Assets	4.75	8.4	4.64	3.49	0.76
Total Current Assets	189.82	257.96	278.27	366.9	108.92
Net Property, Plant & Equipment	49.91	57.66	65.15	33.26	21.89
Long-Term Investments	2.15	3.45	10.68	7.81	6.42
Other Long-Term Assets	6.06	5.54	10.74	6.52	4.77
Total Assets	247.94	324.6	364.84	414.49	141.99
Accounts Payable	1.22	0.53	1.79	2.01	1.35
Accrued Expenses	9.9	8.42	11.47	8.79	3.53
Current Portion of Leases	5.57	5.59	3.43	1.52	0.69
Unearned Revenue	12.9	22.76	48.91	34.69	19.6
Other Current Liabilities	-	-	3.27	1.54	-
Total Current Liabilities	29.58	37.31	68.86	48.54	25.17
Long-Term Debt	-	-	-	-	30.28
Long-Term Leases	36.09	40.19	44.8	17.06	17.97
Other Long-Term Liabilities	3.82	12.25	36.01	77.22	24.63
Total Long-Term Liabilities	39.91	52.43	80.81	94.27	72.87
Total Liabilities	69.49	89.74	149.67	142.81	98.04
Common Stock	0	0	-	0.03	0.03
Additional Paid-in Capital	466.41	457.15	9.46	2.51	0.55
Accumulated Other Comprehensive Income	0.37	0.71	-0.1	-0.27	-0.02
Retained Earnings	-288.34	-223	-144.94	-76.69	-33.1
Total Common Shareholders' Equity	178.45	234.86	-135.58	-74.43	-32.54
Minority Interest	-	-	350.76	346.1	76.5
Shareholders' Equity	178.45	234.86	215.17	271.68	43.95
Total Liabilities & Equity	247.94	324.6	364.84	414.49	141.99
Total Debt	41.66	45.78	48.23	18.57	48.93
Net Cash (Debt)	142.45	202.53	222.95	343.56	59.23
Net Cash Growth	-29.66%	-9.16%	-35.10%	480.08%	-
Net Cash Per Share	3.83	6.13	65.49	101.06	-
Book Value	178.45	234.86	-135.58	-74.43	-32.54
Book Value Per Share	4.80	7.11	-39.82	-21.89	-
Tangible Book Value	178.45	234.86	-135.58	-74.43	-32.54
Tangible Book Value Per Share	4.80	7.11	-39.82	-21.89	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q